The FDA sent notice today that Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years. 

U.S. News & World Report's annual rankings of heart hospitals named Cleveland Clinic No. 1, once again, but there were many changes among the other top 25 hospitals. 

The first patient was enrolled in a multicenter clinical trial for the TaurusTrio transcatheter aortic valve replacement system, used for aortic regurgitation.

Several key trends at the 2023 annual meeting of the Society of Cardiovascular Computed Tomography were outlined by society President Ed Nicol, MD, including AI, reimbursement issue, business management discussions, and a growing interest in cardiac CT leading to record attendance this year.

Valentin Fuster, MD, PhD, one of the world’s most prominent cardiologists, said "it is now our responsibility to ensure these treatments are widely available and used by the medical community.”

COVID-19 opened the eyes of many cardiology researchers that infections may promote inflammation in atherosclerotic plaques, leading to cardiac events.